Savara (SVRA) Share-based Compensation (IS) (2019 - 2026)
Savara (SVRA) reported Share-based Compensation (IS) of $7.77 million for Q2 2026, up 190.9% from $2.67 million a year earlier but down 27.6% from the prior quarter.
Powered by 
Analysis
Savara (SVRA) Share-based Compensation (IS) (2019 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Savara's Share-based Compensation (IS) came in at $27.27 million, up 146.9% year-over-year; for FY2025, it came in at $14.42 million, up 46.3% from FY2024.
- Share-based Compensation (IS) has increased for three consecutive years, with a four-year compound annual growth rate of 45.0% (FY2021 to FY2025).
- By year, Share-based Compensation (IS) came in at $9.86 million in FY2024 (+136.0%), $4.18 million in FY2023 (+104.7%), $2.04 million in FY2022 (-37.4%) and $3.26 million in FY2021.
- Five-year quarterly Share-based Compensation (IS) spans a low of $450,000 in Q3 2022 and a high of $10.73 million in Q1 2026.
- Year over year, Share-based Compensation (IS) has now increased in each of the last five quarters, with growth averaging 122.2% over the last seven quarters.
- The high point for year-over-year Share-based Compensation (IS) in five years was Q1 2026 (growth of 260.9%); the low point was Q2 2022 (a decline of 40.9%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $10.73 million (Q1 2026), $5.36 million (Q4 2025) and $3.43 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | - |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | - |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | - |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | - |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | - |
| 10 | Savara | 1.04 Bn | 1.04 Bn | - | 7.77 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 7.77 Mn |
| Mar 31, 2026 | 10.73 Mn |
| Dec 31, 2025 | 5.36 Mn |
| Sep 30, 2025 | 3.43 Mn |
| Jun 30, 2025 | 2.67 Mn |
| Mar 31, 2025 | 2.97 Mn |
| Dec 31, 2024 | 3.04 Mn |
| Sep 30, 2024 | 2.37 Mn |
| Jun 30, 2024 | 2.20 Mn |
| Dec 31, 2023 | 1.36 Mn |
| Sep 30, 2023 | 995,000.00 |
| Jun 30, 2023 | 958,000.00 |
| Mar 31, 2023 | 864,000.00 |
| Dec 31, 2022 | 561,000.00 |
| Sep 30, 2022 | 450,000.00 |
| Jun 30, 2022 | 456,000.00 |
| Mar 31, 2022 | 574,000.00 |
| Dec 31, 2021 | 853,000.00 |
| Sep 30, 2021 | 690,000.00 |
| Jun 30, 2021 | 771,000.00 |
API Access
Savara Share-based Compensation (IS) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation-is&ticker=SVRA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation-is", "ticker": "SVRA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation-is&ticker=SVRA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();